Northwire Canada EditionFriday, July 24, 2026
Sign inSubscribe
Northwire
⌕
AVX 0.005 −nan% AII 19.91 −1.0% GWM 0.480 +0.0% GEN 0.065 +0.0% NIO 0.135 −3.6% III 7.22 −2.8% NCAU 0.295 −3.3% NEV 0.040 +0.0% ITR 3.00 −1.6% ALDE 2.79 −0.7% TECK 84.18 +4.4% FVI 11.83 −2.2% SUM 1.31 −1.5% RSMX 0.115 +4.5% STW 0.105 +5.0% PAT 0.250 +0.0% AVX 0.005 −nan% AII 19.91 −1.0% GWM 0.480 +0.0% GEN 0.065 +0.0% NIO 0.135 −3.6% III 7.22 −2.8% NCAU 0.295 −3.3% NEV 0.040 +0.0% ITR 3.00 −1.6% ALDE 2.79 −0.7% TECK 84.18 +4.4% FVI 11.83 −2.2% SUM 1.31 −1.5% RSMX 0.115 +4.5% STW 0.105 +5.0% PAT 0.250 +0.0%
Earnings

Profound Medical to release Q2 results Aug. 14

By The Northwire Desk — AI Analysis Jul 24, 2025 · 22:47 PRN · 8.04 Profound Medical Corp
PRN · Price

Executive Summary

  • Profound Medical Corp. will release its second quarter 2025 financial results after the market close on Thursday, August 14, 2025.
  • Management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments.
  • The call will be broadcast live and archived on the company's website.

Key Details

  • Release Date: Thursday, August 14, 2025.
  • Release Time: After the market close.
  • Conference Call Time: 4:30 p.m. ET.
  • Registration: Online registration is available for the live call.
  • Archival: The call will be broadcast live and archived on the company's website under the investors section webcasts.

Notable Quotes

  • None provided in the release text.
Read the original news release →

More from Profound Medical Corp

May 15, 2026 · 06:30

Profound Medical Corp.

Other May 14, 2026 · 07:00

TULSA-PRO's Conference Glow Hides a Long Road to Profitability

Other May 07, 2026 · 16:05

Humana coverage and surging procedure volumes push TULSA-PRO toward standard of care, but path to profitability still requires execution.

Earnings Mar 27, 2026 · 15:15

Profound talks up Tulsa procedure milestone in Texas

Production / Operations Mar 27, 2026 · 07:45

Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure(TM) Milestone

Other Mar 13, 2026 · 10:30

CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure(TM) to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence

Other